Ligand Pharmaceuticals (LGND)
NASDAQ: LGND
· Real-Time Price · USD
167.96
1.42 (0.85%)
At close: Sep 04, 2025, 12:05 PM
Rylaze Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.86M | -255K | -8.18% |
| Mar 31, 2025 | 3.12M | n/a | n/a |
| Dec 31, 2024 | n/a | n/a | n/a |
| Sep 30, 2024 | 3.89M | 654K | +20.24% |
| Jun 30, 2024 | 3.23M | 280K | +9.49% |
| Mar 31, 2024 | 2.95M | n/a | n/a |
| Dec 31, 2023 | n/a | n/a | n/a |
| Sep 30, 2023 | n/a | n/a | n/a |
| Jun 30, 2023 | n/a | n/a | n/a |
| Mar 31, 2023 | n/a | n/a | n/a |
| Dec 31, 2022 | n/a | n/a | n/a |
| Sep 30, 2022 | n/a | n/a | n/a |
| Jun 30, 2022 | n/a | n/a | n/a |
| Mar 31, 2022 | n/a | n/a | n/a |
| Dec 31, 2021 | n/a | n/a | n/a |
| Sep 30, 2021 | n/a | n/a | n/a |
| Jun 30, 2021 | n/a | n/a | n/a |
| Mar 31, 2021 | n/a | n/a | n/a |
| Dec 31, 2020 | n/a | n/a | n/a |
| Sep 30, 2020 | n/a | n/a | n/a |
| Jun 30, 2020 | n/a | n/a | n/a |
| Mar 31, 2020 | n/a | n/a | n/a |
| Jun 30, 2018 | n/a | n/a | n/a |
| Mar 31, 2018 | n/a | n/a | n/a |